Inhalation Anesthesia Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope
Inhalation anesthesia refers to medications used in operating rooms to induce and maintain general anesthesia. In addition to other therapeutic effects, it causes drowsiness that ranges from mild to severe, up to and including general anesthesia. Inhalation anesthesia is used for the induction and maintenance of general anesthesia in the operating room.

Sizing and Forecast
The inhalation anesthesia market size has grown strongly in recent years. It will grow from $1.46 billion in 2023 to $1.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to growing surgical procedures requiring anesthesia, increased geriatric population, development of inhalation anesthetics, expansion of ambulatory surgical centers, increasing prevalence of chronic diseases such as heart disease and cancer.

The inhalation anesthesia market size is expected to see strong growth in the next few years. It will grow to $2.14 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rising demand for minimally invasive surgeries, growing global healthcare expenditure, increasing number of surgical procedures in emerging markets, adoption of inhalation anesthesia in veterinary medicine, increased government funds for r&d of innovative inhalation anesthetics. Major trends in the forecast period include technological innovations in anesthesia delivery systems, development of inhalation anesthesia devices for pediatric use, shift towards sevoflurane and desflurane, focus on eco-friendly anesthetic agents, integration of monitoring technologies in anesthesia delivery.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report

Segmentation & Regional Insights
The inhalation anesthesia market covered in this report is segmented –

1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide
2) By Application: Induction, Maintenance
3) By End User: Hospitals, Ambulatory Surgical Centers

North America was the largest region in the inhalation anesthesia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7198&type=smp

Major Driver Impacting Market Growth
The increasing geriatric population is anticipated to propel the growth of inhalation anesthesia during the forecast period. The increasing geriatric population is boosting the inhalation anesthesia market as they are highly prone to degenerative diseases and chronic illnesses, which eventually leads to a rise in surgeries and therapeutics. Moreover, the increasing geriatric population, which is more susceptible to ailments, such as cardiovascular, neurological, respiratory, and degenerative disorders, is boosting the market growth. It is usually inconvenient to administer anesthesia through an intravenous route to geriatric patients due to punctured blood vessels and issues with patient compliance. For instance, in October 2022, according to the World Health Organization, a Switzerland-based international public health organization, the global population of individuals aged 60 years is projected to increase to 1.4 billion by 2022 compared to 1 billion in 2020. Moreover, 1 out of 6 people in the world will be aged more than 60 years or older by 2030. Therefore, the increasing geriatric population is expected to boost demand for inhalation anesthesia during the forecast period.

Key Industry Players
Major companies operating in the inhalation anesthesia market report are Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, B. Braun Melsungen AG, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co. Ltd., Mylan N. V., Piramal Enterprises Ltd., Recipharm AB, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Wockhardt Ltd., AstraZeneca PLC, C. H. Boehringer Sohn AG & Co. KG, Bristol-Myers Squibb Company, Eisai Co. Ltd., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S. A., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, UCB S. A., Zydus Lifesciences Limited

The inhalation anesthesia market report table of contents includes:

1. Executive Summary

2. Inhalation Anesthesia Market Characteristics

3. Inhalation Anesthesia Market Trends And Strategies

4. Inhalation Anesthesia Market – Macro Economic Scenario

5. Global Inhalation Anesthesia Market Size and Growth

.
.
.

31. Global Inhalation Anesthesia Market Competitive Benchmarking

32. Global Inhalation Anesthesia Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Inhalation Anesthesia Market

34. Inhalation Anesthesia Market Future Outlook and Potential Analysis

35. Appendix

Top Major Players:

Abbvie Inc.

Baxter International Inc.

Halocarbon Products Corporation

Hikma Pharmaceuticals PLC

B. Braun Melsungen AG

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info 

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
Twitter: https://twitter.com/tbrc_info 
Facebook: https://www.facebook.com/TheBusinessResearchCompany 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 
Blog: https://blog.tbrc.info/ 
Healthcare Blog: https://healthcareresearchreports.com/ 
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model